股票行情快报：英科医疗（300677）2月25日主力资金净卖出3192.88万元

Group 1 - The core viewpoint of the news is that Yingke Medical (300677) has shown a mixed performance in its financial results, with a notable increase in net profit but a decline in revenue for the third quarter of 2025 [2] - As of February 25, 2026, Yingke Medical's stock closed at 41.75 yuan, with a slight increase of 0.48% and a trading volume of 62,700 hands, resulting in a total transaction amount of 262 million yuan [1] - The net outflow of main funds on February 25 was 31.93 million yuan, accounting for 12.16% of the total transaction amount, while retail investors saw a net inflow of 48.47 million yuan, representing 18.47% of the total transaction amount [1] Group 2 - For the first three quarters of 2025, Yingke Medical reported a main revenue of 7.425 billion yuan, an increase of 4.6% year-on-year, and a net profit attributable to shareholders of 924 million yuan, up 34.47% year-on-year [2] - The third quarter of 2025 saw a single-quarter main revenue of 2.511 billion yuan, a decrease of 2.9% year-on-year, while the single-quarter net profit attributable to shareholders was 214 million yuan, an increase of 113.04% year-on-year [2] - The company has a debt ratio of 53.79%, with investment income of 183 million yuan and financial expenses of 127 million yuan, while the gross profit margin stands at 23.7% [2]